Xcytrin
Xcytrin
Xcytrin (pronounced eks-SEE-trin), also known as motexafin gadolinium, is a synthetic, low molecular weight, paramagnetic complex that is used in the treatment of brain metastases associated with non-small cell lung cancer (NSCLC).
Etymology
The term "Xcytrin" is a brand name, and its etymology is not publicly disclosed. However, its generic name, "motexafin gadolinium," is derived from its chemical composition. "Motexafin" is a portmanteau of the chemical components involved in its synthesis, while "gadolinium" refers to the rare earth metal used in its formulation.
Usage
Xcytrin is used as a radiosensitizer to enhance the effectiveness of radiation therapy in treating brain metastases from NSCLC. It works by selectively accumulating in cancer cells and generating reactive oxygen species when exposed to radiation, thereby increasing the damage to cancer cells.
Related Terms
- Radiosensitizer: A drug that makes tumor cells more sensitive to radiation therapy.
- Brain metastases: Cancer that has spread to the brain from another part of the body.
- Non-small cell lung cancer (NSCLC): The most common type of lung cancer.
- Radiation therapy: The use of high-energy radiation to kill cancer cells and shrink tumors.
See Also
External links
- Medical encyclopedia article on Xcytrin
- Wikipedia's article - Xcytrin
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski